Phototherapy: a promising treatment option for skin sclerosis in scleroderma?
C Sunderkötter, A Kuhn, N Hunzelmann… - Rheumatology, 2006 - academic.oup.com
In systemic sclerosis (SSc; scleroderma) fibrosis of the skin can lead to considerable
morbidity. No significant improvement has been reported from studies investigating …
morbidity. No significant improvement has been reported from studies investigating …
Extracorporeal photopheresis: clinical use so far
KW Sanford, RA Balogun - Journal of Clinical Apheresis, 2012 - Wiley Online Library
Extracorporeal photopheresis (ECP or photopheresis) is an advanced therapeutic apheresis
procedure in which blood is separated into its various components and the isolated buffy …
procedure in which blood is separated into its various components and the isolated buffy …
Recent advances in phototherapy
JC Simon, D Pfieger, E Schöpf - European Journal of Dermatology, 2000 - jle.com
This synopsis reviews recent developments in dermatological phototherapy. UVA1
phototherapy (340-400 nm) is effective in the treatment of inflammatory skin diseases such …
phototherapy (340-400 nm) is effective in the treatment of inflammatory skin diseases such …
Incidence of lung cancer in patients with systemic sclerosis treated with extracorporeal photopheresis
S Topuzoglu, R Knobler, O Movadat… - Photodermatology …, 2015 - Wiley Online Library
Background Extracorporeal photopheresis (ECP) improves skin sclerosis in systemic
sclerosis (SS c) patients. SSc is associated with an increased risk of lung cancer. As ECP is …
sclerosis (SS c) patients. SSc is associated with an increased risk of lung cancer. As ECP is …
Extracorporeal photopheresis in dermatology
L Pérez-Carmona, A Harto-Castaño… - Actas Dermo …, 2009 - Elsevier
Extracorporeal photochemotherapy or photopheresis is an immunomodulatory therapy that
combines leukapheresis with phototherapy. Blood from the patient is processed to give a …
combines leukapheresis with phototherapy. Blood from the patient is processed to give a …
[HTML][HTML] Extracorporeal photochemotherapy does not suppress T-or B-cell responses to novel or recall antigens
KR Suchin, M Cassin, R Washko, G Nahass… - Journal of the American …, 1999 - Elsevier
Background: Extracorporeal photopheresis (ExP) is an effective therapy for several
conditions including cutaneous T-cell lymphoma, scleroderma, and allograft rejection …
conditions including cutaneous T-cell lymphoma, scleroderma, and allograft rejection …
Extracorporeal photopheresis: what is it and when should it be used?
J Scarisbrick - Clinical and experimental dermatology, 2009 - academic.oup.com
Extracorporeal photopheresis (ECP) is a technique that was developed> 20 years ago to
treat erythrodermic cutaneous T‐cell lymphoma (CTCL). The technique involves removal of …
treat erythrodermic cutaneous T‐cell lymphoma (CTCL). The technique involves removal of …
Photopheresis: current and future perspectives
EC Vonderheid - Journal of Cutaneous Medicine and Surgery …, 2003 - Springer
Extracorporeal photopheresis (ECP), also known as extracorporeal photochemotherapy or
photoimmunotherapy, is the brainchild of Richard Edelson, MD, currently Professor and …
photoimmunotherapy, is the brainchild of Richard Edelson, MD, currently Professor and …
Immunomodulatory effects of extracorporeal photochemotherapy in systemic sclerosis
The aim of this study was to evaluate the clinical and immunomodulatory effects of
extracorporeal photochemotherapy (ECP) in systemic sclerosis (SSc). We enrolled 16 …
extracorporeal photochemotherapy (ECP) in systemic sclerosis (SSc). We enrolled 16 …
Extracorporeal Photopheresis in Dermatological Diseases
H Terhaar, M Saleem, N Yusuf - International Journal of Molecular …, 2024 - mdpi.com
Extracorporeal photopheresis (ECP) is an apheresis procedure that is conventionally used
as a first-line treatment for cutaneous and leukemic subtypes of T-cell lymphoma, such as …
as a first-line treatment for cutaneous and leukemic subtypes of T-cell lymphoma, such as …